Artisan Partners Limited Partnership Grows Stock Holdings in Celcuity Inc. (NASDAQ:CELC)

Artisan Partners Limited Partnership boosted its holdings in shares of Celcuity Inc. (NASDAQ:CELC - Free Report) by 18.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 491,507 shares of the company's stock after buying an additional 75,830 shares during the quarter. Artisan Partners Limited Partnership owned 1.32% of Celcuity worth $6,434,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CELC. Corebridge Financial Inc. raised its stake in shares of Celcuity by 12.9% in the fourth quarter. Corebridge Financial Inc. now owns 16,256 shares of the company's stock valued at $213,000 after acquiring an additional 1,858 shares in the last quarter. New York State Common Retirement Fund increased its holdings in Celcuity by 14.9% during the 4th quarter. New York State Common Retirement Fund now owns 28,391 shares of the company's stock worth $372,000 after purchasing an additional 3,682 shares during the period. Rhumbline Advisers raised its position in Celcuity by 20.6% in the 4th quarter. Rhumbline Advisers now owns 38,755 shares of the company's stock valued at $507,000 after purchasing an additional 6,625 shares in the last quarter. SG Americas Securities LLC raised its position in Celcuity by 83.2% in the 4th quarter. SG Americas Securities LLC now owns 14,646 shares of the company's stock valued at $192,000 after purchasing an additional 6,651 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in shares of Celcuity by 20.3% in the 4th quarter. Bank of New York Mellon Corp now owns 64,125 shares of the company's stock valued at $839,000 after buying an additional 10,828 shares during the period. Hedge funds and other institutional investors own 63.33% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on CELC shares. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 price target on shares of Celcuity in a research note on Tuesday. HC Wainwright restated a "buy" rating and set a $27.00 target price on shares of Celcuity in a research note on Tuesday. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $30.17.

Celcuity Stock Performance

Shares of Celcuity stock traded down $0.07 on Wednesday, hitting $9.22. The stock had a trading volume of 190,058 shares, compared to its average volume of 291,405. The stock has a market cap of $342.34 million, a price-to-earnings ratio of -3.48 and a beta of 0.44. The company has a current ratio of 10.35, a quick ratio of 10.36 and a debt-to-equity ratio of 0.65. Celcuity Inc. has a 52-week low of $8.50 and a 52-week high of $20.89. The company's 50 day moving average price is $11.14 and its 200 day moving average price is $12.87.

Celcuity (NASDAQ:CELC - Get Free Report) last issued its quarterly earnings data on Monday, March 31st. The company reported ($0.85) earnings per share for the quarter, missing analysts' consensus estimates of ($0.72) by ($0.13). On average, research analysts anticipate that Celcuity Inc. will post -2.62 EPS for the current year.

About Celcuity

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.